Document is current
Any future updates will be listed below
-
Authors
Wei, Jian-Xiang https://orcid.org/0000-0001-9052-9212
Wang, Jing
Zhu, Yun-Xia
Sun, Jun
Xu, Hou-Ming
Li, Ming
-
Funding
Funding for this research was provided by:
National Social Science Foundation (14BTQ036)
- License Information
-
More Information
Article History
Received: 3 November 2016
Accepted: 5 March 2018
First Online: 9 March 2018
Ethics approval and consent to participate
: According to “Adverse Drug Reaction Reporting and Monitoring Management Regulation” (No.81 Order of Ministry of Health of China,), all ADR reports are collected by voluntary way. The ADR data in this paper was provided by CFDA and it did not contain individual information of the patients. For all studies mentioned in this manuscript, no approval of the ethical review board was needed according to “Ethical Review Involving Human Biomedical Research” (No.11 Order of National Health and Family Planning Commission of China,); only human subject research with a high impact for patients have to be reviewed.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
